Dual add on therapy in type 2 diabetes poorly controlled with metformin monotherapy: A randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin - Rosenstock, J; Hansen, L; Zee, P (Diabetes Care, 2015)
et al.